Overview
- Editors:
-
-
Akitane Mori
-
Okayama University Medical School, Okayama, Japan
-
Burton D. Cohen
-
The Bronx Lebanon Hospital Center, Bronx, USA
-
Hikaru Koide
-
Juntendo University School of Medicine, Tokyo, Japan
Access this book
Other ways to access
Table of contents (41 chapters)
-
Physiological, Pharmacological and Toxicological Aspects of Guanidino Compounds
-
- Masayoshi Hirata, Shuichi Hatakeyama, Katsuo Haruki, Hiroaki Muramoto, Yohei Tofuku, Ryoyu Takeda
Pages 135-136
-
- Yoshiyuki Takano, Fumitake Gejyo, Yoshio Shirokane, Moto-o Nakajima, Masaaki Arakawa
Pages 137-146
-
- Seiji Sugimoto, Yoji Ochiai, Michio Kitaura, Koji Kabutan, Chiaki Tsuji, Yoshinori Kosogabe et al.
Pages 147-151
-
- Takaaki Obata, Akitane Mori, Henry I. Yamamura
Pages 153-157
-
- Hideki Sugi, Isao Yokoi, Yoko Watanabe, Akitane Mori
Pages 159-164
-
Involvement of Seizure Mechanism
-
Front Matter
Pages 167-167
-
- Isao Yokoi, Akira Edaki, Yoko Watanabe, Yoshihisa Shimizu, Hiroko Toda, Akitane Mori
Pages 169-181
-
- Shoichiro Shindo, Douglas W. Bonhaus, Ryan J. Huxtable
Pages 183-187
-
- Ryan J. Huxtable, Anders Lehmann, Mats Sandberg, Shoichiro Shindo
Pages 189-197
-
- Peter Wiecherf, Bart Marescau, Peter P. De Deyn, Luth Van Gorp, Werner P. De Potter, Armand Lowenthal
Pages 199-202
-
- Bart Marescau, Peter P. De Deyn, Lut Van Gorp, Werner P. De Potter, Armand Lowenthal, Peter Wiechert et al.
Pages 203-212
-
- Hiroshi Shiraga, Midori Hiramatsu, Akitane Mori
Pages 213-222
-
Hyperargininemia
-
Front Matter
Pages 223-223
-
- Armand Lowenthal, Bart Marescau
Pages 225-231
-
- Naoki Mizutani, Chiemi Hayakawa, Yukihiro Oya, Kazuyoshi Watanabe, Yoko Watanabe, Akitane Mori
Pages 233-243
-
- Bart Marescau, Ijaz A. Qureshi, Peter P. De Deyn, Jacques Letarte, Nestor Chamoles, Makoto Yoshino et al.
Pages 245-249
-
- Peter P. De Deyn, Robert L. Macdonald, Bart Marescau, Armand Lowenthal
Pages 251-257
-
Involvement of Giuanidino Compounds in Renal Dysfunction
-
Front Matter
Pages 259-259
-
- Yasushi Suzuki, Fumitake Gejyo, Masaaki Arakawa
Pages 261-265
-
- Sohji Nagase, Kazumasa Aoyagi, Masako Sakamoto, Mitsuhiro Miyazaki, Shoji Ohba, Mitsuharu Narita et al.
Pages 267-275
About this book
Guanidine is named for its similarity to the purine guanine which, in turn, is named for its principal source guano, which comes from the Inca word, huano, for dung. Guanidine, therefore, translates into dung-like, which is hardly a genteel way to introduce a subject. On the other hand, texts are seldom inspirational, "frequently crude and rarely literary and should be judged on how successfully they assemble, organize and present current data. I am impressed that the material which fol]ows goes a long way toward successfully achieving those goals. Tue International Guanidine Society is a synthesis of three groups of investigators: biologists studying guanidines as phosphagens, neurologists interested in guanidines as convulsants and nephrologists involved with guanidines as toxins. As a member of the latter group. I am gratified by the considerable progress this book represents. To begin with. there now appears to be a common theme which unifies current speculation concerning the metabolic origin of the guanidines in uremia. At the First International Congress in 1983, evidence was presented which supported the theory that certain guanidines were products of the mixed function oxidation of urea. This year's meeting brings together overwhelming data showing that methyl guanidine is an effect of active oxygen reacting with creatinine. An idolatry, worshipped throughout biochemistry, that urea and creatinine are inert byproducts of protein metabolism, is shown to have feet of clay.
Editors and Affiliations
-
Okayama University Medical School, Okayama, Japan
Akitane Mori
-
The Bronx Lebanon Hospital Center, Bronx, USA
Burton D. Cohen
-
Juntendo University School of Medicine, Tokyo, Japan
Hikaru Koide